LAG3 and myeloid sarcoma: On the other hand, studies on EAE models have shown that LAG-3 deficiency in CD4+ FoxP3+ Tregs in the CNS enhances IFN-γ and granzyme B production, which, in contrast to Tregs' protective role in maintaining immune tolerance, shifts them toward a contributor to MS pathogenesis [111].